deferoxamine has been researched along with methylcellulose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becton, DL; Roberts, B | 1 |
| Chell, S; Cheng, K; DeAngelis, E; Jones, NM; Nathanson, AD; Whelan, G; Willé, D | 1 |
2 other study(ies) available for deferoxamine and methylcellulose
| Article | Year |
|---|---|
Antileukemic effects of deferoxamine on human myeloid leukemia cell lines.
Topics: Antineoplastic Agents; Cell Division; Deferoxamine; DNA, Neoplasm; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid; Methylcellulose; Neoplasm Proteins; RNA, Neoplasm; Time Factors; Tumor Cells, Cultured | 1989 |
The prolyl hydroxylase inhibitor GSK1120360A reduces early brain injury, but protection is not maintained in a neonatal rat model of hypoxic ischaemic encephalopathy.
Topics: Animals; Animals, Newborn; Brain; Brain Injuries; Deferoxamine; Hypoxia; Hypoxia-Ischemia, Brain; Methylcellulose; Neuroprotective Agents; Prolyl-Hydroxylase Inhibitors; Rats; Rats, Sprague-Dawley | 2022 |